Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule polymerization in helminths refers to the assembly of microtubules from α- and β-tubulin heterodimers, a process essential for cell division, motility, and cell morphology in helminthic parasites. This process is targeted by several anti-helminthic drugs (such as albendazole) and cancer therapeutics (colchicine, vinblastine, taxol), which either inhibit or stabilize microtubules. Disruption of microtubule dynamics impairs vital parasite functions and can lead to cell death. Tubulin and microtubule polymerization are validated drug targets in eukaryotic pathogens including helminths, though selective targeting is challenging due to high conservation of tubulin between helminths and host cells.
Inhibition of microtubule polymerization (by colchicine, vinblastine) - Stabilization of microtubules to prevent disassembly (by taxol) - Disruption of microtubule assembly-disassembly dynamics leading to impaired cell division and parasite death
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule polymerization protein (helminth).